AtaiBeckley Inc.

Annual Trend FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($157.4m) ($43.9m) ($150.0m) ($660.1m) ($663.5m)
Net loss ($150.0m) ($660.1m)
Net Income (Loss) Attributable to Parent ($152.4m)
($40.2m) +73.60%
($149.3m) -271.09%
($660.0m) -342.19%
Net Income (Loss) Attributable to Noncontrolling Interest ($780k) ($100k)
Depreciation, Depletion and Amortization $168k $319k $473k $1.0m $963k
Depreciation $168k $319k $200k $600k $963k
Amortization of Intangible Assets $200k $400k
Depreciation and amortization of long-term assets $473k $1.0m $963k
Amortization of debt discount $515k $176k
Depreciation Amortization Depletion $168k $319k $473k $1.0m $963k
Deferred Income Tax Expense (Benefit) $0 $0 $0
Deferred Income Tax $0 $5.1m $0 $0
Deferred Tax $0 $5.1m $0 $0
Share-based Payment Arrangement, Noncash Expense $25.5m $14.2m $16.3m
Stock-based compensation expense $25.5m $14.2m $16.3m
Impairment of Intangible Assets, Finite-lived $919k $33k
Asset Impairment Charge $852k $1.0m $3.6m $33k $33k
Income (Loss) from Equity Method Investments ($2.0m) $0
Other Nonoperating Income (Expense) $5.5m ($3.1m)
Losses from investments in equity method investees, net of tax $2.0m $0
Earnings (Loss)es From Equity Investments $16.0m $3.6m $2.0m $0 $0
Nonoperating Income (Expense) ($45.7m) ($15.8m)
Changes in operating assets and liabilities:
Change In Working Capital ($3.3m) $7.5m ($9.2m) ($6.5m) ($2.7m)
Increase (Decrease) in Accounts Payable ($1.9m) ($1.7m) $4.2m
Common stock issuance costs in accounts payable and accrued liabilities $0 $6k $198.4m
Change In Payables And Accrued Expense ($1.8m) ($1.2m) ($8.8m) ($7.9m) $4.2m
Accrued liabilities ($7.0m) ($6.2m) ($8.9m)
Deferred revenue $721k $766k
Change In Accrued Expense $1.2m ($3.3m) ($7.0m) ($6.2m) ($8.9m)
Gain (Loss) on Disposition of Other Assets $0 ($692k)
Prepaid expenses and other current assets ($1.1m) $691k
Net Cash Provided by (Used in) Operating Activities ($104.5m)
($84.1m) +19.48%
($82.4m) +2.00%
($102.7m) -24.55%
($105.9m) -3.16%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment ($6k) $700k $522.7m
Payments to Acquire Property, Plant, and Equipment ($1.0m) ($590k) $6k $901k ($10.9m)
Capital Expenditure Reported ($251k) ($331k) ($89k) $0 ($10.9m)
Gain on other investments ($1.3m) ($3.8m)
Cash paid for investments ($15.0m) ($10.0m)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $65.6m $0
Restricted Cash and Investments, Current $10.0m $0
Net Other Investing Changes ($3.0m) ($5.5m) ($7.7m) ($10.0m) ($10.0m)
Net Cash Provided by (Used in) Investing Activities $59.2m ($109.1m) ($119.8m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt $0 ($1.3m)
Loss on extinguishment of debt $0 $1.3m
Cash paid for debt financing costs ($161k) $0
Cash paid for debt extinguishment $0 ($21.8m)
Proceeds from debt financing $5.0m $0
Issuance Of Debt $15.0m $0 $5.0m $0 $0
Long Term Debt Issuance $15.0m $0 $5.0m $0 $0
Net Issuance Payments Of Debt $15.0m $0 $5.0m $0 $0
Issuance Of Capital Stock $600k $0 $0 $258.1m $198.4m
Repurchase Of Capital Stock $0 ($6.6m) ($6.6m)
Cash paid for common stock and pre-funded warrant issuance costs $0 ($6.6m)
Common Stock Issuance $409.9m $0 $0 $258.1m $198.4m
Common Stock Payments $0 ($6.6m) ($6.6m)
Proceeds from other financing $0 $148k
Net Other Financing Charges $2.9m ($8.6m) ($161k) ($14.0m) ($14.0m)
Net Cash Provided by (Used in) Financing Activities $5.4m
$269.5m +4914.53%
$210.7m -21.81%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($17.5m) $57.8m $43.3m
Beginning Cash Position $362.3m $190.6m $45.0m $27.5m $58.3m
Cash, cash equivalents and restricted cash - beginning of the period $27.5m $85.3m
Net decrease in cash, cash equivalents and restricted cash ($17.5m) $57.8m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.5m $85.3m $43.3m
Effect of foreign exchange rate changes on cash $362k $116k
Effect Of Exchange Rate Changes ($1.1m) $189k $362k $116k ($192k)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Income Tax Expense (Benefit) ($356k) $298k
Interest Expense Nonoperating $3.1m $1.2m
Right of use asset obtained in exchange for operating lease liabilities $0 $1.7m
Additional Financial Items
Proceeds from Stock Options Exercised $535k $10.4m
Fair Value, Option, Changes in Fair Value, Gain (Loss) $3.8m $3.1m
Foreign Currency Transaction Gain (Loss), before Tax ($1.3m) $1.9m
Foreign Currency Transaction Gain (Loss), Unrealized ($1.1m) $2.0m
Gain (Loss) on Termination of Lease $0 ($408k)
General and Administrative Expense $47.5m $65.1m
Goodwill $331k $331k $33k
Investment Income, Interest $778k $1.5m
Operating Expenses $103.0m $648.1m
Payments of Financing Costs $161k $0
Restructuring Costs $2.0m $2.9m
Noncash lease expense $416k $413k
Noncash change in the fair value of assets and liabilities, net $51.6m $26.0m
Acquisition of in-process research and development $0 ($6.9m)
Loss on disposal of fixed assets $0 $692k
Loss on lease termination $0 $408k
Gain on dissolution of a variable interest entity ($1.2m) $0
Gain on settlement of pre-existing contract ($5.6m) $0
Noncash change in the fair value of digital assets, net $0 $1.2m
Unrealized foreign exchange (gain) $1.1m ($2.0m)
Issuance costs allocated to pre-funded warrants $0 $1.4m
Other income, net ($2.4m) ($182k)
Proceeds from sale and maturities of securities carried at fair value $65.6m $0
Cash received in acquisition of IntelGenx Corp. $359k $0
Cash received in acquisition of Beckley Psytech Limited $0 $4.6m
Cash paid for securities carried at fair value $0 ($88.9m)
Cash paid for digital assets $0 ($10.0m)
Cash paid for Psilera asset acquisition $0 ($3.0m)
Cash paid for short-term convertible notes receivable and warrant - related party ($2.0m) $0
Cash paid for short-term notes receivable - related party ($5.7m) ($10.0m)
Cash paid for capitalized internal-use software development costs ($6k) $0
Cash paid for intangible asset ($83k) $0
Proceeds from equity offerings, net of commissions $0 $258.1m
Proceeds from issuance of pre-funded warrants $0 $21.5m
Proceeds from conversion of convertible notes to common shares $0 $7.7m
Proceeds from issuance of shares upon exercise of stock options $535k $10.4m
Noncash exchange of convertible promissory note modification $3.6m $0
Discharge of notes receivable $5.4m $0
Noncash consideration for acquisition of Beckley Psytech $0 $519.6m
Noncash transaction costs for services rendered to Beckley Psytech $0 $4.0m
Noncash consideration for variable interest deconsolidation $115k $0
Cash Flow From Continuing Financing Activities $20.8m ($8.4m) $5.4m $269.5m $210.7m
Cash Flow From Continuing Investing Activities ($86.8m) ($53.3m) $59.2m ($109.1m) ($119.8m)
Change In Account Payable ($3.0m) $2.1m ($1.9m) ($1.7m) $4.2m
Change In Other Working Capital ($6.0m) $721k $766k $1.1m
Change In Payable ($3.0m) $2.1m ($1.9m) ($1.7m) $4.2m
Change In Prepaid Assets ($1.5m) $8.7m ($1.1m) $691k $933k
Changes In Cash ($170.5m) ($145.8m) ($17.9m) $57.7m ($15.0m)
End Cash Position $190.6m $45.0m $27.5m $85.3m $43.3m
Financing Cash Flow $20.8m
($8.4m) -140.20%
$5.4m +164.32%
$269.5m +4914.53%
$210.7m -21.81%
Free Cash Flow ($105.5m) ($84.7m) ($82.5m) ($113.5m) ($111.5m)
Gain Loss On Investment Securities $46k ($336k) ($1.3m) $527.6m $527.6m
Gain Loss On Sale Of Business ($1.5m) ($60k) ($1.2m) ($6.9m) ($6.9m)
Gain Loss On Sale Of PPE $0 $692k $692k
Investing Cash Flow ($86.8m) ($53.3m) $59.2m ($109.1m) ($119.8m)
Net Business Purchase And Sale $0 ($443k) $359k $4.6m $4.6m
Net Foreign Currency Exchange Gain Loss ($5.0m) $799k $1.1m ($2.0m) ($1.2m)
Net Intangibles Purchase And Sale $0 $0 ($10.0m) ($5.0m)
Net PPE Purchase And Sale ($773k) ($259k) ($6k) ($901k) ($633k)
Net Preferred Stock Issuance $0 $600k $0
Operating Gains Losses $9.6m $4.3m $652k $521.9m $522.7m
Other Non Cash Items ($1.8m) ($86.3m) $44.5m $26.8m
Proceeds From Stock Option Exercised $2.3m $205k $535k $31.9m $32.4m
Purchase Of Business ($52.9m) $0 ($443k) $0 ($3.0m)
Purchase Of Intangibles $0 $0 ($10.0m) ($5.0m)
Purchase Of PPE ($773k) ($259k) ($6k) ($901k) ($10.9m)
Sale Of Business $0 $359k $4.6m $4.6m
Stock Based Compensation $42.4m $33.0m $25.5m $14.2m $16.3m
Unrealized Gain Loss On Investment Securities ($272k) $0 $2.1m $0 $1.8m
Net Investment Purchase And Sale ($82.8m) ($46.7m) $66.7m ($92.9m) ($109.6m)
Purchase Of Investment ($309.7m) ($186.2m) ($15.0m) ($101.9m) ($128.1m)
Loss on sale of investment held at fair value $2.1m $0
Noncash loss on sale of investment held at fair value $2.7m $0
Proceeds from sale of other investment held at fair value $16.1m $9.1m
Sale Of Investment $226.8m $139.5m $81.7m $9.1m $18.5m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($171.7m) ($145.6m) ($17.5m) $57.8m
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.9m $2.2m $793k
Income Taxes Paid, Net $1.5m $411k $589k